Chemotargets

Silver Sponsor

Chemotargets is a drug discovery and development company that offers validated and cutting-edge computational methodologies with market-leading predictive performance. We have developed a set of tools based on artificial intelligence to identify, optimise, and secure the optimal safety profile for new drug candidates. The application of these tools enables the rapid identification of molecular properties that can address important unmet medical needs. Chemotargets’ goal is to help the biopharma industry fast-forward the process of bringing new medicines to market, by speeding up drug discovery and development programmes, and improving cost-efficiency and safety.

The technological platforms developed at Chemotargets include: CLARITY (https://chemotargets.com/clarity/) for predictive off-target pharmacology and medicinal chemistry; CLARITY Suite (https://chemotargets.com/clarity-pv/), for translational safety; and ProSurfScan (https://chemotargets.com/services/discovery/) for AI-guided de novo drug design.

CLARITY Suite (claritypv.com) is a translational safety platform for medicinal products and vaccines safety surveillance, that contains highly-curated and integrated data connecting safety findings across all phases of a medicine’s lifetime, from Safety Pharmacology, through Preclinical Toxicology and Clinical Safety, all the way up to Postmarketing Reports and Real World Data and Evidence.

We work with partners worldwide through software licensing, services and drug discovery projects.

website